| The long lifespan and low turnover of human islet beta cells estimated by mathematical modelling of lipofuscin accumulation M Cnop, SJ Hughes, M Igoillo-Esteve, MB Hoppa, F Sayyed, ... Diabetologia 53, 321-330, 2010 | 250 | 2010 |
| Adverse effects of androgen‐deprivation therapy in prostate cancer and their management H Rhee, JH Gunter, P Heathcote, K Ho, P Stricker, NM Corcoran, ... BJU international 115, 3-13, 2015 | 146 | 2015 |
| The fatty acid synthase inhibitor triclosan: repurposing an anti-microbial agent for targeting prostate cancer MC Sadowski, RH Pouwer, JH Gunter, AA Lubik, RJ Quinn, CC Nelson Oncotarget 5 (19), 9362, 2014 | 146 | 2014 |
| Insulin Increases De Novo Steroidogenesis in Prostate Cancer Cells AA Lubik, JH Gunter, SC Hendy, JA Locke, HH Adomat, V Thompson, ... Cancer Research 71 (17), 5754-5764, 2011 | 135 | 2011 |
| Adverse physicochemical properties of tripalmitin in beta cells lead to morphological changes and lipotoxicity in vitro JH Moffitt, BA Fielding, R Evershed, R Berstan, JM Currie, A Clark Diabetologia 48, 1819-1829, 2005 | 131 | 2005 |
| A molecular portrait of epithelial–mesenchymal plasticity in prostate cancer associated with clinical outcome N Stylianou, ML Lehman, C Wang, AT Fard, A Rockstroh, L Fazli, ... Oncogene 38 (7), 913-934, 2019 | 88 | 2019 |
| Different characteristics and nucleotide binding properties of inosine monophosphate dehydrogenase (IMPDH) isoforms EC Thomas, JH Gunter, JA Webster, NL Schieber, V Oorschot, RG Parton, ... PloS one 7 (12), e51096, 2012 | 85 | 2012 |
| Neuropilin-1 is upregulated in the adaptive response of prostate tumors to androgen-targeted therapies and is prognostic of metastatic progression and patient mortality BWC Tse, M Volpert, E Ratther, N Stylianou, M Nouri, K McGowan, ... Oncogene 36 (24), 3417-3427, 2017 | 81 | 2017 |
| Emergence of microRNAs as key players in cancer cell metabolism S Subramaniam, V Jeet, JA Clements, JH Gunter, J Batra Clinical chemistry 65 (9), 1090-1101, 2019 | 69 | 2019 |
| Characterisation of inosine monophosphate dehydrogenase expression during retinal development: differences between variants and isoforms JH Gunter, EC Thomas, N Lengefeld, SJ Kruger, L Worton, EM Gardiner, ... The international journal of biochemistry & cell biology 40 (9), 1716-1728, 2008 | 64 | 2008 |
| IGF2 increases de novo steroidogenesis in prostate cancer cells AA Lubik, JH Gunter, BG Hollier, S Ettinger, L Fazli, N Stylianou, ... Endocrine-related cancer 20 (2), 173-186, 2013 | 59 | 2013 |
| Class IIa histone deacetylases drive toll-like receptor-inducible glycolysis and macrophage inflammatory responses via pyruvate kinase M2 KD Gupta, MR Shakespear, JEB Curson, AMV Murthy, A Iyer, MP Hodson, ... Cell reports 30 (8), 2712-2728. e8, 2020 | 54 | 2020 |
| Dominant negative mutant forms of the cAMP response element binding protein induce apoptosis and decrease the anti-apoptotic action of growth factors in human islets SA Sarkar, J Gunter, R Bouchard, JEB Reusch, A Wiseman, RG Gill, ... Diabetologia 50, 1649-1659, 2007 | 43 | 2007 |
| New players for advanced prostate cancer and the rationalisation of insulin-sensitising medication JH Gunter, PL Sarkar, AA Lubik, CC Nelson International journal of cell biology 2013, 2013 | 42 | 2013 |
| Revisiting glycogen in cancer: a conspicuous and targetable enabler of malignant transformation T Khan, MA Sullivan, JH Gunter, T Kryza, N Lyons, Y He, JD Hooper Frontiers in Oncology 10, 592455, 2020 | 36 | 2020 |
| The interactions between insulin and androgens in progression to castrate-resistant prostate cancer JH Gunter, AA Lubik, I McKenzie, M Pollak, CC Nelson Advances in urology 2012, 2012 | 30 | 2012 |
| Insulin enhances migration and invasion in prostate cancer cells by up-regulation of FOXC2 PL Sarkar, W Lee, ED Williams, AA Lubik, N Stylianou, A Shokoohmand, ... Frontiers in Endocrinology 10, 481, 2019 | 27 | 2019 |
| Apolipoprotein E genotype, islet amyloid deposition and severity of Type 2 diabetes DS Powell, H Maksoud, SBP Chargé, JH Moffitt, M Desai, RLDS Fihlo, ... Diabetes research and clinical practice 60 (2), 105-110, 2003 | 26 | 2003 |
| Repositioning “old” drugs for new causes: identifying new inhibitors of prostate cancer cell migration and invasion ET Shah, A Upadhyaya, LK Philp, T Tang, D Skalamera, J Gunter, ... Clinical & Experimental Metastasis 33, 385-399, 2016 | 23 | 2016 |
| Islet amyloid polypeptide gene promoter polymorphisms are not associated with type 2 diabetes or with the severity of islet amyloidosis C Esapa, JH Moffitt, A Novials, CM McNamara, JC Levy, M Laakso, ... Biochimica et Biophysica Acta (BBA)-Molecular Basis of Disease 1740 (1), 74-78, 2005 | 18 | 2005 |
Colleen NelsonQueensland University of TechnologyVerified email at qut.edu.au
